FDA approval expands access to artificial heart valve for inoperable patients

Written on:September 27, 2013
Comments are closed

The U.S. Food and Drug Administration has approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the device available to an expanded group of patients who have inoperable aortic valve stenosis, a disease of the heart valves that causes narrowing of the aortic valve, restricting blood flow from the heart…

Source: Medical Devices


Sorry, the comment form is closed at this time.